Weil Company’s Patterson-UTI PTEN Stock Holding History

Weil Company’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-8,000	Closed	-$68K	–	272
2019 Q3	$68K	Buy	+8,000	New	+$78.5K	0.05%	163

Other funds holding PTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Weil Company's PTEN Position: Q4 2019 in Review

Weil Company sold out of Patterson-UTI (PTEN) in Q4 2019, closing a stake of 8,000 shares — an estimated $68K sold.

Weil Company first reported a position in PTEN in Q3 2019 and held it in 1 quarter. The position peaked at $68K in Q3 2019. 267 funds tracked by Wall St. Rank hold PTEN as of Q4 2019.

Weil Company reported no remaining Patterson-UTI position as of Q4 2019 after selling out during the quarter.
Weil Company sold 8,000 Patterson-UTI shares in Q4 2019, an estimated $68K.
Weil Company first reported a position in Patterson-UTI in Q3 2019 and held it in 1 quarter.
Weil Company's Patterson-UTI position peaked at $68K in Q3 2019.
267 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2019.

Based on Weil Company's 13F filing for Q4 2019, filed 13 Feb 2020.